Risk factors for thrombocytopenia in hiv-infected persons in the era of potent antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 52, Issue 5, 2009, Pages 595-599

  Marks, Kristen M ^a   Clarke, Robin M A ^a,d   Bussel, James B ^b   Talal, Andrew H ^c   Glesby, Marshall J ^a  

^a Division of Infectious Diseases   (United States)

^b Division of Hematology and Oncology   (Taiwan)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UCLA MEDICAL CENTER   (United States)

Author keywords

Hepatitis C; HIV; Thrombocytopenia

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID; IMMUNOGLOBULIN; VINCRISTINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG POTENCY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIREMIA; ADOLESCENT; CASE CONTROL STUDY; CLINICAL TRIAL; IMMUNOLOGY; MEDICAL RECORD; MIDDLE AGED; MULTICENTER STUDY; RETROSPECTIVE STUDY; UNITED STATES;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CASE-CONTROL STUDIES; FEMALE; HEMORRHAGE; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; MALE; MEDICAL RECORDS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOCYTOPENIA; UNITED STATES;

EID: 70449634674     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181b79aff     Document Type: Article

References (18)

1. Carbonara S, Fiorentino G, Serio G, et al. Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors. J Infect. 2001;42:251-256.
2. Sullivan PS, Hanson DL, Chu SY, et al. Surveillance for thrombocyto-penia in persons infected with HIV: results from the multistate Adult and Adolescent Spectrum of Disease Project. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:374-379.
3. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocyto-penic purpura (ITP) of adults and children: report from an International Working Group. Blood. 2009;113:2386-2393.
4. Servais J, Nkoghe D, Schmit JC, et al. HIV-associated hematologic disorders are correlated with plasma viral load and improve under highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;28: 221-225.
5. Nardi MA, Liu LX, Karpatkin S. GPIIIa-(49-66) is a major pathophysio-logically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia. Proc Natl Acad Sci U S A. 1997; 94:7589-7594.
6. Oksenhendler E, Bierling P, Ferchal F, et al. Zidovudine for thrombo-cytopenic purpura related to human immunodeficiency virus (HIV) infection. Ann Intern Med. 1989;110:365-368.
7. Giannini E, Botta F, Borro P, et al. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am J Gastroenterol. 2003;98: 2516-2520.
8. Giannini E, Borro P, Botta F, et al. Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J Hepatol. 2002;37:572-577.
9. Adinolfi LE, Giordano MG, Andreana A, et al. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br J Haematol. 2001;113:590-595.
10. Bauduer F, Marty F, Larrouy M, et al. Immunologic thrombocytopenic purpura as presenting symptom of hepatitis C infection. Am J Hematol. 1998;57:338-340.
11. Pockros PJ, Duchini A, McMillan R, et al. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 2002;97:2040-2045.
12. Rajan SK, Espina BM, Liebman HA. Hepatitis C virus-related thrombo-cytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura. Br J Haematol. 2005;129:818-824.
13. Sanjo A, Satoi J, Ohnishi A, et al. Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases. J Gastroenterol Hepatol. 2003;18:638-644.
14. Pereira J, Accatino L, Alfaro J, et al. Platelet autoantibodies in patients with chronic liver disease. Am J Hematol. 1995;50:173-178.
15. Kajiwara E, Akagi K, Azuma K, et al. Evidence for an immunological pathogenesis of thrombocytopenia in chronic liver disease. Am J Gastroenterol. 1995;90:962-966.
16. Pearce CL, Mack WJ, Levine AM, et al. Thrombocytopenia is a strong predictor of all-cause and AIDS-specific mortality in women with HIV: the women's interagency HIV study. Blood. 2004;104: 569A-570A.
17. Rieg G, Yeaman M, Lail AE, et al. Platelet count is associated with plasma HIV type 1 RNA and disease progression. AIDS Res Hum Retroviruses. 2007;23:1257-1261.
18. Holzman RS, Walsh CM, Karpatkin S. Risk for the acquired immunodeficiency syndrome among thrombocytopenic and nonthrom-bocytopenic homosexual men seropositive for the human immunodeficiency virus. Ann Intern Med. 1987;106:383-386.